Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert Lai

Showing results (131-140 of 209) with videos related to

Pageof 21
Sort By:
Neuro-Oncology|November 2, 2012
Overexpression of isocitrate dehydrogenase mutant proteins renders glioma cells more sensitive to radiationSichen Li, Arthur P Chou, Weidong Chen, et al.
Journal of Neuro-Oncology|September 2, 2022
Relapse patterns and radiation dose exposure in IDH wild-type glioblastoma at first radiographic recurrence following chemoradiationSatoka Shidoh, Ricky R Savjani, Nicholas S Cho, et al.
Clinical Epigenetics|July 28, 2022
Distinct modulation of IFNγ-induced transcription by BET bromodomain and catalytic P300/CBP inhibition in breast cancerSimon J Hogg, Olga Motorna, Conor J Kearney, et al.
Neuro-Oncology Practice|August 7, 2019
Bevacizumab at first recurrence after standard radio-chemotherapy is associated with improved overall survival in glioblastoma patients with large tumor burdenHuy Tram Nguyen, Nhung Nguyen, Liang Yen Liu, et al.
Neuro-Oncology Advances|April 28, 2026
Clinical and radiographic prognostic factors in recurrent contrast-enhancing IDH-mutant gliomas treated with bevacizumabCollin T Le, Francesco Sanvito, Chuyin Yang, et al.
Journal of Molecular Biology|April 24, 2017
Rationally Designed PI3Kα Mutants to Mimic ATR and Their Use to Understand Binding Specificity of ATR InhibitorsYipin Lu, Mark Knapp, Kenneth Crawford, et al.
Journal of Neuro-Oncology|January 30, 2014
C-terminally truncated form of αB-crystallin is associated with IDH1 R132H mutation in anaplastic astrocytomaNuraly K Avliyakulov, Kavitha S Rajavel, Khanh Minh T Le, et al.
Molecular Cancer|November 8, 2015
Bone morphogenetic protein 7 sensitizes O6-methylguanine methyltransferase expressing-glioblastoma stem cells to clinically relevant dose of temozolomideJonathan L Tso, Shuai Yang, Jimmy C Menjivar, et al.
Oncotarget|April 18, 2018
A gene expression signature predicts recurrence-free survival in meningiomaAdriana Olar, Lindsey D Goodman, Khalida M Wani, et al.
Cancer Research|February 13, 2013
Response classification based on a minimal model of glioblastoma growth is prognostic for clinical outcomes and distinguishes progression from pseudoprogressionMaxwell Lewis Neal, Andrew D Trister, Sunyoung Ahn, et al.
Pageof 21

Showing results (131-140 of 209) with videos related to

Sort By:
Pageof 21
Neuro-Oncology|November 2, 2012
Overexpression of isocitrate dehydrogenase mutant proteins renders glioma cells more sensitive to radiationSichen Li, Arthur P Chou, Weidong Chen, et al.
Journal of Neuro-Oncology|September 2, 2022
Relapse patterns and radiation dose exposure in IDH wild-type glioblastoma at first radiographic recurrence following chemoradiationSatoka Shidoh, Ricky R Savjani, Nicholas S Cho, et al.
Clinical Epigenetics|July 28, 2022
Distinct modulation of IFNγ-induced transcription by BET bromodomain and catalytic P300/CBP inhibition in breast cancerSimon J Hogg, Olga Motorna, Conor J Kearney, et al.
Neuro-Oncology Practice|August 7, 2019
Bevacizumab at first recurrence after standard radio-chemotherapy is associated with improved overall survival in glioblastoma patients with large tumor burdenHuy Tram Nguyen, Nhung Nguyen, Liang Yen Liu, et al.
Neuro-Oncology Advances|April 28, 2026
Clinical and radiographic prognostic factors in recurrent contrast-enhancing IDH-mutant gliomas treated with bevacizumabCollin T Le, Francesco Sanvito, Chuyin Yang, et al.
Journal of Molecular Biology|April 24, 2017
Rationally Designed PI3Kα Mutants to Mimic ATR and Their Use to Understand Binding Specificity of ATR InhibitorsYipin Lu, Mark Knapp, Kenneth Crawford, et al.
Journal of Neuro-Oncology|January 30, 2014
C-terminally truncated form of αB-crystallin is associated with IDH1 R132H mutation in anaplastic astrocytomaNuraly K Avliyakulov, Kavitha S Rajavel, Khanh Minh T Le, et al.
Molecular Cancer|November 8, 2015
Bone morphogenetic protein 7 sensitizes O6-methylguanine methyltransferase expressing-glioblastoma stem cells to clinically relevant dose of temozolomideJonathan L Tso, Shuai Yang, Jimmy C Menjivar, et al.
Oncotarget|April 18, 2018
A gene expression signature predicts recurrence-free survival in meningiomaAdriana Olar, Lindsey D Goodman, Khalida M Wani, et al.
Cancer Research|February 13, 2013
Response classification based on a minimal model of glioblastoma growth is prognostic for clinical outcomes and distinguishes progression from pseudoprogressionMaxwell Lewis Neal, Andrew D Trister, Sunyoung Ahn, et al.
Pageof 21